A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication
Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Bo‐Jian Zheng(University of Hong Kong), Richard Yi Tsun Kao(University of Hong Kong), Jie Zhou(Chinese University of Hong Kong), Ke Zhang(Guiyang Medical University), Jiahui Ye(Shanxi Medical University), Kailash Singh(University of Hong Kong), Hin Chu(University of Hong Kong), Bkc Chow(University of Hong Kong)
Cited by 36
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility
|Clinical Infectious Diseases|2020|1.2k
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
|Nature|2022|858